Neurochemical mechanisms in soman-induced seizures

Journal of Applied Toxicology

Volumn 17, Issue 4, 1997, Pages 255-264

  Shih, Tsung Ming ^a   McDonough Jr , John H ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Acetylcholine; Catecholamines; Cholinesterase; Excitatory amino acids; Inhibitory amino acids; Organophosphorus compound; Seizure activity; Soman

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMINO ACID; ASPARTIC ACID; CHOLINESTERASE; DOPAMINE; GLUTAMIC ACID; HOMOVANILLIC ACID; NEUROTRANSMITTER; NORADRENALIN; SOMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ELECTROENCEPHALOGRAM; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CATECHOLAMINES; CHOLINESTERASE INHIBITORS; ELECTROENCEPHALOGRAPHY; MALE; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; SOMAN; SPINAL CORD;

ANIMALIA;

EID: 0030839411     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.0.CO;2-D     Document Type: Article

References (65)

1. P. Taylor, Anticholinesterase agents. In The Pharmacological Basis of Therapeutics, 6th Edn, ed. by A. G. Gilman, L. S. Goodman, T. W Rail and F. Murad, pp. 110-129. Macmillan, New York (1985).
2. W Berry and D. R. Davis, The use of carbamates and atropine in protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem. Pharmacol. 19, 927-934 (1970).
3. J. J Gordon, L. Leadbeater and M P. Maidment, The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl Pharmacol 43, 207-216 (1978).
4. P. Dirnhuber, M. C French, D M Green, L Leadbeater and J A. Stratton, The protection of primates against soman poisoning by pretreatment with pyridostigmine J Pharm Pharmacol 31, 295-299 (1979)
5. L. Leadbeater, R H Inns and J M Rylands, Treatment of poisoning by soman Fundam Appl Toxicol 5, S225-S231 (1985)
6. W M. Kluwe, J W. Chinn, J. W Feder, C. Olson and R. Joiner, Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model In Proceedings of the Sixth Medical Chemical Defense Bioscience Review, AD No B121516, pp 227-234 US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD (1987).
7. J. M Petras, Soman neurotoxicity. Fundam. Appl. Toxicol 1, 242 (1981).
8. J. M Petras, Neurology and neuropathology of soman-induced brain injury an overview J. Exp. Anal. Behav 61, 319-329 (1994).
9. K R Thornton and G S. Fukuyama. Morphological changes in the brain of M Mulatta treated for VX poisoning with atropine, metaraminol and P2S. Suffield Tech. Pap No 228 (1961)
10. K R Thornton and E G Brigden, Morphological changes in the brains of guinea pigs following VX poisoning, Suffield Tech Pap No 230 (1962)
11. G. Lemercier, P. Carpentier, H. Sentenac-Roumanou and P. Moralis, Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organosphosphorus compound. Acta Neuropathol. (Berlin) 61, 123-129 (1983).
12. F. E. Samson, T. L. Pazdernik, R. S. Cross, L. Churchill, M P. Giesler and S. R. Nelson, Brain regional activity and damage associated with organophosphate induced seizures: effects of atropine and benactyzine. Proc. West. Pharmacol. Soc. 28, 183-185 (1985).
13. T. L. Pazdernik, R. Cross, M. Giesler, S. Nelson, F. Samson and J. H. McDonough, Delayed effects of soman: brain glucose use and pathology. NeuroToxicology 6, 61-70 (1985).
14. L. Churchill, T. L. Pazdernik, J. L. Jackson, S R. Nelson, F. E. Samson, J. H. McDonough and C. G. McLeod, Soman-induced brain lesions demonstrated by muscarinic receptor autoradiography. NeuroToxicology 6, 81-90 (1985).
15. C. G. McLeod, A. W. Singer and D. G. Harrington, Acute neuropathology in soman poisoned rats. NeuroToxicology 5, 53-58 (1984).
16. C. G. McLeod, Pathology of nerve agents: perspectives on medical management. Fundam. Appl. Toxicol. 5, S10-S16 (1985).
17. J. H. McDonough, C. G. McLeod and M T. Nipwoda, Direct micro-injection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res. 435, 123-137 (1987).
18. J. H. McDonough, N K. Jaax, R A. Crowley, M. Z. Mays and H. E. Modrow, Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl Toxicol. 13, 256-276 (1989).
19. J. H. McDonough, L. W Dochterman, C D. Smith and T.-M. Shih, Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment NeuroToxicology 15, 123-132 (1995).
20. M. A. Dunn and F. R. Sidell, Progress in medical defense against nerve agents. J. Am. Med. Assoc. 262, 649-652 (1989).
21. D. H. Moore, C. B Clifford, I. T. Crawford, G. M Cole and J. M. Baggett, Review of nerve agent inhibitors and reactivators of acetylcholinesterase In Enzymes of Cholinesterase Family, ed by D. M Quinn, A. S. Balasubramanian, B. P Doctor and P. Taylor, pp. 297-304. Plenum Press, New York (1995).
22. J. A. Lipp, Effect of diazepam upon soman-mduced seizure activity and convulsions EEG Clin. Neurophys. 32, 557-560 (1972).
23. J. A. Lipp, Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch. Int. Pharmacodyn Ther. 202, 244-251 (1973).
24. S. Rump, E. Grudzinska and Z. Edelwein, Effects of diazepam on abnormalities of bioelectrical activity of the rabbit's brain due to fluostigmine. Acta Nerv. Super. (Prague) 14, 176-177 (1972).
25. S. Rump, E Grudzinska and Z. Edelwein, Effects of diazepam on epileptiform patterns of bioelectrical activity of the rabbit's brain induced by fluostigmine. Neuropharmacology 12, 813-817 (1973).
26. J. A. Vale and G. W. Scott, Organophosphorus poisoning. Guy's Hosp. Rep. 123, 13-25 (1974).
27. D. D Johnson and H. E Lowndes, Reduction by diazepam of repetitive electrical activity and toxicity resulting from soman Eur J. Pharmacol 28, 245-250 (1974)
28. D. D. Johnson and W C Wilcox, Studies on the mechanism of the protective and antidotal actions of diazepam in organophosphate poisoning Eur. J Pharmacol 34, 127-132 (1975).
29. B. Boskovic, The treatment of soman poisoning and its perspectives Fundam Appl Toxicol. 1, 203-213 (1981).
30. L. J Martin, J A Doebler, T -M Shih and A Anthony, Protective effect of diazepam pretreatment on soman-induced brain lesion formation Brain Res 325, 287-289 (1985)
31. I J Hayward, M G Wall, N K Jaax, J V Wade, D. D Marlow and J B Nold, Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J. Neurol. Sci. 98, 99-106 (1990).
32. J. H. McDonough and T -M. Shih, Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17, 203-215 (1993).
33. T.-M. Shih, Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 7, 105-116 (1990).
34. T.-M. Shih, T. A. Koviak and B. R. Capacio, Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci. Biobehav. Rev. 15, 349-362 (1991).
35. J. W. Olney, R. C Collins and R. S. Sloviter, Excitotoxic mechanisms of epileptic brain damage. Adv. Neurol. 44, 857-878 (1986).
36. K. E. Misulis, M. E. Clinton, W.-D. Dettbarn and R. C. Gupta, Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase. Toxicol. Appl. Pharmacol. 89, 391-398 (1987).
37. T.-M. Shih, C. E. Whalley and J. J. Valdes, A comparison of cholmergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol. Lett. 55, 131-147 (1991).
38. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd Edn. Academic Press, New York (1986).
39. 3H]DOPA in various regions of the brain. J. Neurochem. 13, 655-669 (1966).
40. V. R. Jimmerson, T.-M. Shih and R. B. Mailman, Variability in soman toxicity in the rat: Correlation with biochemical and behavioral measures. Toxicology 57: 241-254 (1989)
41. W. A. Groff, A. Kaminskis and R. I. Ellin Interconversion of cholinesterase enzyme activity units by the manual pH method and a recommended automated method Clin. Toxicol 9, 353-358 (1976).
42. T.-M. Shih, B. R. Capacio and L. A. Cook, Effects of anticholinergic-antiparkinsonian drugs on striatal neurotransmitter levels of rats intoxicated with soman Pharmacol. Biochem. Behav 44, 615-622 (1993).
43. D. J. Jenden and I. Hanin, Gas Chromatographic microestimate of choline and acetylcholine after N-demethylation by sodium benzenethiolate. In Choline and Acetylcholine: Handbook of Chemical Assay Methods, ed. by I. Hanin, pp. 133-150. Raven Press, New York (1974).
44. T.-M Shih, Time course effects of soman on acetylcholine and cholme levels in six discrete areas of the rat brain. Psychopharmacologia (Berlin) 78, 170-175 (1982).
45. T.-M. Shih, D. E Lenz and D. M. Maxwell, Effects of repeated injection of sublethal doses of soman on behavior and on brain acetylcholine and choline concentrations in the rat. Psychopharmacology 101, 489-496 (1990)
46. P. Fosbraey, J. R Wetherall and M. C. French, Neurotransmitter changes in guinea-pig brain regions following soman intoxication J. Neurochem. 54, 72-79 (1990).
47. G. Lallement, P. Carpentier, A. Collet, D. Baubichon, I. Pernot Marino and G Blanchet, Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. NeuroToxicology 13, 557-568 (1992).
48. G. Lallement, M. Denoyer, A Collet, I. Pernot-Marino, D. Baubichon, P Monmaur and G. Blanchet, Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures, influence of septal cholinoceptive cells. Neurosci. Lett 139, 104-107 (1992).
49. G Blanchet, P. Carpentier, G Lallement, A Tarricone, H. Sentenac and J.-M Kamenka, Anticonvulsant effect of N-[1-(2-thienyl)cyclohexyl]-piperidine (TCP) in soman poisoning In Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Protection, ed. by J -M Kamenka and E F Domino, pp. 831-840. NPP Books, Ann Arbor, (1992)
50. S Sparenborg, L H Brennecke, N. K Jaax and D. J. Braitman, Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology 31, 357-368 (1997)
51. T M Shih, J H McDonough and I. Koplovitz Evaluation of anticonvulsant drugs for soman-induced seizure activity J Am Coll Toxicol 15 (Suppl 2), S43-S60 (1996)
52. G. Lallement, P. Carpentier, A Collet, I. Pernot-Marino, D. Baubichon and G. Blanchet, Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 563, 234-240 (1991).
53. G. Lallement, P. Carpentier, A. Collet, I. Pernot-Marino, D. Baubichon, H. Sentenac-Roumanou and G. Blanchet, Involvement of glutamatergic system in amygdala during soman-induced seizures: comparison with the hippocampus, Series III, pp. 421-426. Comptes Rendus, Academy of Science, Paris (1991).
54. B. R Capacio and T.-M. Shih, Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia 32, 604-615 (1991)
55. M. M. El-Etri, W. T. Nickell, M. Ennis, K. A Skau and M. Shipley, Brain norepinephrine reductions in soman-intoxicated rats: association with convulsions and AChE inhibition, time course, and relation to other monoamines. Exp. Neurol. 118, 153-163 (1992).
56. J. V. Wade, F. E. Samson, S. R. Nelson and T. L. Pazdernik, Changes in extracellular amino acids during soman- and kainic acid-induced seizure. J. Neurochem. 49, 645-650 (1987).
57. G. Lallement, I. Pernot-Marino, A. Foquin-Tarricone, D. Baubichon, A. Piras, G. Blanchet and P. Carpentier, Coadministration of atropine, NBQX and TCP against soman-induced seizures. NeuroReport 5, 1113-1117 (1994).
58. J. W. Olney, M. T. Price, J. Labruyere, K S Salles, G. Frierdrich, M. Mueller and E. Silverman, Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur. J. Pharmacol. 142, 319-320 (1987).
59. J. H. McDonough and T.-M. Shih, A study of the N-methyl-D-aspartate antagonistic properties of anticholnergic drugs Pharmacol. Biochem. Behav. 51, 249-253 (1995)
60. G Lallement, P. Carpentier, I. Pernot-Manno, D. Baubichon, A. Collet and G Blanchet, Involvement of the differ ent rat hippocampal glutamatergic receptors in development of seizures induced by soman. an autoradiographic study. NeuroToxicology 12, 655-664 (1991).
61. R. S. Sloviter and D. W. Dempster, 'Epileptic' brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res. Bull. 15, 39-60 (1985)
62. M L. Mayer and G. L. Westbrook, Cellular mechanisms underlying excitotoxicity Trend. Neurosci. 10, 59-61 (1987).
63. P. Carpentier, I. S. Delamanche, M. Le Bert, G. Blanchet and C. Bouchaud, Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. NeuroToxicology 11, 493-508 (1990).
64. J. P. Petrali, D M. Maxwell, D. E. Lenz and K. R. Mills, Effect of an anticholmesterase compound on the ultrastructure and function of the rat blood-brain barrier a review and experiment. J. Submicrosc. Cytol. Pathol 23, 331-338 (1991).
65. D. J. Braitman and S. Sparenborg, MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res. Bull 23, 145-148 (1989).